Cohen-Mekelburg S, Rosenblatt R, Gold S, Shen N, Fortune B, Waljee AK, Saini S, Scherl E, Burakoff R, Unruh M.
2019.
Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes.. Am J Gastroenterol. 114(2):276-290.
RoyChoudhury A, Dam T-TL, Xu C, Diah JH, Chaganty D, Solares J, Fried LP.
2019.
Feed-forward loop between body composition, strength and performance in older adults.. Mech Ageing Dev. 183:111130.
Russell D, Baik D, Jordan L, Dooley F, Hummel SL, Prigerson HG, Bowles KH, Creber RMasterson.
2019.
Factors Associated With Live Discharge of Heart Failure Patients From Hospice: A Multimethod Study.. JACC Heart Fail. 7(7):550-557.
Creber RMMasterso, Baldwin MR, Brown PJ, Rao MK, Goyal P, Hummel S, Dodson JA, Helmke S, Maurer MS.
2019.
Facilitated Peer Mentorship to Support Aging Research: A RE-AIM Evaluation of the CoMPAdRE Program.. J Am Geriatr Soc. 67(4):804-810.
Nabbout R, Arzimanoglou A, Chin RFM, Grinspan Z, Speechley K, Camfield P.
2019.
The evaluation and costs of transition programs for youth with epilepsy.. Epilepsy Behav. 93:133-137.
Nabbout R, Arzimanoglou A, Chin RFM, Grinspan Z, Speechley K, Camfield P.
2019.
The evaluation and costs of transition programs for youth with epilepsy.. Epilepsy Behav. 93:133-137.
Creber RMMasterso, Grossman LV, Ryan B, Qian M, Polubriaginof FCG, Restaino S, Bakken S, Hripcsak G, Vawdrey DK.
2019.
Engaging hospitalized patients with personalized health information: a randomized trial of an inpatient portal.. J Am Med Inform Assoc. 26(2):115-123.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.